Cargando…

Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension

The pattern of the left ventricle (LV) has important significance in adults with hypertension. The aim of the present study was to analyze changes and determinants of LV geometry after 1 year of antihypertensive treatment in children with primary hypertension (PH) in relation to metabolic abnormalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Śladowska-Kozłowska, Joanna, Litwin, Mieczysław, Niemirska, Anna, Wierzbicka, Aldona, Wawer, Zbigniew T., Janas, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203224/
https://www.ncbi.nlm.nih.gov/pubmed/21626453
http://dx.doi.org/10.1007/s00467-011-1916-8
_version_ 1782215092791672832
author Śladowska-Kozłowska, Joanna
Litwin, Mieczysław
Niemirska, Anna
Wierzbicka, Aldona
Wawer, Zbigniew T.
Janas, Roman
author_facet Śladowska-Kozłowska, Joanna
Litwin, Mieczysław
Niemirska, Anna
Wierzbicka, Aldona
Wawer, Zbigniew T.
Janas, Roman
author_sort Śladowska-Kozłowska, Joanna
collection PubMed
description The pattern of the left ventricle (LV) has important significance in adults with hypertension. The aim of the present study was to analyze changes and determinants of LV geometry after 1 year of antihypertensive treatment in children with primary hypertension (PH) in relation to metabolic abnormalities and anthropometrical parameters. In 86 children (14.1 ± 2.4 years) with newly diagnosed PH, LV geometry and biochemical parameters before and after 12 months of standard antihypertensive therapy were assessed. At baseline, normal LV geometry (NG) was found in 42 (48.9%), concentric remodeling (CR) in 4 (4.6%), concentric hypertrophy (CH) in 8 (9.3%), and eccentric hypertrophy (EH) in 32 (37.2%) patients. The prevalence of NG in patients with severe hypertension was significantly lower than in patients with ambulatory hypertension. There were no differences in dipping status in relation to LV geometry. Patients with CH and EH were more viscerally obese than patients with NG. Patients with CH had higher diastolic blood pressure in comparison with EH patients (p < 0.05). The main predictor of relative wall thickness (RWT) was the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio (R(2) = 0.319, β = 0.246, p = 0.004). Patients received 12 months of antihypertensive treatment, either lifestyle modification only (n = 37) or lifestyle modification plus antihypertensive medications (n = 49) if severe ambulatory hypertension or target organ damage were present. After 12 months of treatment the prevalence of EH (37.2% vs 18.6%, p = 0.003) decreased but prevalence of CH did not change. Patients in whom RWT decreased also decreased waist circumference and TG/HDL; the main predictor of RWT decrease was a decrease of the TG/HDL ratio (β = 0.496, R(2) = 0.329, p = 0.002). In adolescents with PH, LV geometry is related to central obesity and insulin resistance. Decrease of abdominal obesity and insulin resistance are the most important predictors of normalization of LV geometry, however CH has lower potential to normalize LV geometry. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-011-1916-8) contains supplementary material that is available to authorized users
format Online
Article
Text
id pubmed-3203224
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-32032242011-11-10 Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension Śladowska-Kozłowska, Joanna Litwin, Mieczysław Niemirska, Anna Wierzbicka, Aldona Wawer, Zbigniew T. Janas, Roman Pediatr Nephrol Original Article The pattern of the left ventricle (LV) has important significance in adults with hypertension. The aim of the present study was to analyze changes and determinants of LV geometry after 1 year of antihypertensive treatment in children with primary hypertension (PH) in relation to metabolic abnormalities and anthropometrical parameters. In 86 children (14.1 ± 2.4 years) with newly diagnosed PH, LV geometry and biochemical parameters before and after 12 months of standard antihypertensive therapy were assessed. At baseline, normal LV geometry (NG) was found in 42 (48.9%), concentric remodeling (CR) in 4 (4.6%), concentric hypertrophy (CH) in 8 (9.3%), and eccentric hypertrophy (EH) in 32 (37.2%) patients. The prevalence of NG in patients with severe hypertension was significantly lower than in patients with ambulatory hypertension. There were no differences in dipping status in relation to LV geometry. Patients with CH and EH were more viscerally obese than patients with NG. Patients with CH had higher diastolic blood pressure in comparison with EH patients (p < 0.05). The main predictor of relative wall thickness (RWT) was the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio (R(2) = 0.319, β = 0.246, p = 0.004). Patients received 12 months of antihypertensive treatment, either lifestyle modification only (n = 37) or lifestyle modification plus antihypertensive medications (n = 49) if severe ambulatory hypertension or target organ damage were present. After 12 months of treatment the prevalence of EH (37.2% vs 18.6%, p = 0.003) decreased but prevalence of CH did not change. Patients in whom RWT decreased also decreased waist circumference and TG/HDL; the main predictor of RWT decrease was a decrease of the TG/HDL ratio (β = 0.496, R(2) = 0.329, p = 0.002). In adolescents with PH, LV geometry is related to central obesity and insulin resistance. Decrease of abdominal obesity and insulin resistance are the most important predictors of normalization of LV geometry, however CH has lower potential to normalize LV geometry. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-011-1916-8) contains supplementary material that is available to authorized users Springer Berlin Heidelberg 2011-12-01 2011 /pmc/articles/PMC3203224/ /pubmed/21626453 http://dx.doi.org/10.1007/s00467-011-1916-8 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/2.0/Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0 (https://creativecommons.org/licenses/by-nc/2.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Śladowska-Kozłowska, Joanna
Litwin, Mieczysław
Niemirska, Anna
Wierzbicka, Aldona
Wawer, Zbigniew T.
Janas, Roman
Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
title Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
title_full Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
title_fullStr Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
title_full_unstemmed Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
title_short Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
title_sort change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203224/
https://www.ncbi.nlm.nih.gov/pubmed/21626453
http://dx.doi.org/10.1007/s00467-011-1916-8
work_keys_str_mv AT sladowskakozłowskajoanna changeinleftventriculargeometryduringantihypertensivetreatmentinchildrenwithprimaryhypertension
AT litwinmieczysław changeinleftventriculargeometryduringantihypertensivetreatmentinchildrenwithprimaryhypertension
AT niemirskaanna changeinleftventriculargeometryduringantihypertensivetreatmentinchildrenwithprimaryhypertension
AT wierzbickaaldona changeinleftventriculargeometryduringantihypertensivetreatmentinchildrenwithprimaryhypertension
AT wawerzbigniewt changeinleftventriculargeometryduringantihypertensivetreatmentinchildrenwithprimaryhypertension
AT janasroman changeinleftventriculargeometryduringantihypertensivetreatmentinchildrenwithprimaryhypertension